Characterization of N-linked oligosaccharides attached to recombinant human antithrombin expressed in the yeast Pichia pastoris

Yeast

Volumn 19, Issue 14, 2002, Pages 1191-1202

  Hirose, Masaaki ^a   Kameyama, Shoju ^a   Ohi, Hideyuki ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Antithrombin; N glycosylation; Oligosaccharide; Phosphomannosylation; Pichia pastoris

Indexed keywords

ALKALINE PHOSPHATASE; AMIDE; ANTITHROMBIN; ASPARAGINE; ASPARAGINE LINKED OLIGOSACCHARIDE; ESTER; HEPARIN; MANNOSE; PENTASACCHARIDE; PHOSPHATE; PROTEOHEPARAN SULFATE;

ADSORPTION; ANION EXCHANGE; ARTICLE; BINDING AFFINITY; BLOOD VESSEL INJURY; CELL LABELING; CONTROLLED STUDY; GLYCOSYLATION; HYDROLYSIS; NONHUMAN; PICHIA PASTORIS; PRIORITY JOURNAL; SURFACE CHARGE; YEAST CELL;

ALKALINE PHOSPHATASE; AMIDOHYDROLASES; ANTITHROMBINS; ASPARAGINE; BINDING SITES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, ION EXCHANGE; GENETIC VECTORS; GLYCOSYLATION; HUMANS; OLIGOSACCHARIDES; PEPTIDE-N4-(N-ACETYL-BETA-GLUCOSAMINYL) ASPARAGINE AMIDASE; PICHIA; RECOMBINANT PROTEINS;

PICHIA; PICHIA PASTORIS;

EID: 0036798483     PISSN: 0749503X     EISSN: None     Source Type: Journal    
DOI: 10.1002/yea.914     Document Type: Article

References (43)

1. Ballou CE. 1990. Isolation, characterization, and properties of Saccharomyces cerevisiae mnn mutants with nonconditional protein glycosylation defects. Methods Enzymol 185: 440-470.
2. Ballou CE. 1982. Yeast cell wall and cell surface. In The Molecular Biology of the Yeast Saccharomyces cerevisiae: Metabolism and Gene Expression, Strathern JN, Jones EW, Broach JR (eds). Cold Spring Harbor Laboratory Press: New York; 335-360.
3. Björk I, Ylinenjärvi K, Olson ST, Hermentin P, Conradt HS, Zettlmeissl G. 1992. Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation. Biochem J 286: 793-800.
4. Bock SC, Wion KL, Vehar GA, Lawn RM. 1982. Cloning and expression of the cDNA for human antithrombin III. Nucleic Acids Res 10: 8113-8125.
5. Bretthauer RK, Castellino FJ. 1999. Review: glycosylation of Pichia pastoris-derived proteins. Biotechnol Appl Biochem 30: 193-200.
6. Bröker M, Ragg H, Karges HE. 1987. Expression of human antithrombin III in Saccharomyces cerevisiae and Schizosaccharomyces pombe. Biochem Biophys Acta 908: 203-213.
7. Carrell RW, Evans DL, Stein PE. 1991. Mobile reactive center of serpins and the control of thrombosis. Nature 353: 576-578.
8. Cefalu WT, Bell-Farrow A, Wang ZQ, Ralapati S. 1991. Determination of furosine in biomedical samples employing an improved hydrolysis and high-performance liquid chromatographic technique. Carbohydr Res 215(1): 117-125.
9. Cereghino JL, Cregg JM. 2000. Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol Rev 24: 45-66.
10. de Agostini AI, Watkins SC, Slayter HS, Youssoufian H, Rosenberg RD. 1990. Localization of anticoagulantly active heparan sulphate proteoglycans in vascular endothelium: antithrombin binding on cultured endothelial cells and perfused rat aorta. J Cell Biol 111: 1293-1304.
11. Edmunds T, Van Patten SM, Pollock J, et al. 1998. Transgenically produced human antithrombin: structural and functional comparison to human plasma-derived antithrombin. Blood 91(12): 4561-4571.
12. Ersdal-Badju E, Lu A, Peng X, et al. 1995. Elimination of glycosylation heterogeneity affecting heparin affinity of recombinant human antithrombin III by expression of a β-like variant in baculovirus-infected insect cells. Biochem J 310: 323-330.
13. Fan B, Crews BC, Turko IV, Choay J, Zettlmeissl G, Gettins P. 1993. Heterogeneity of recombinant human antithrombin III expressed in baby hamster kidney cells. J Biol Chem 268(23): 17 588-17 596.
14. Franzén LE, Svensson S, Larm O. 1980. Structural studies on the carbohydrate portion of human antithrombin III. J Biol Chem 255(11): 5090-5093.
15. Gillespie LS, Hillesland KK, Knauer DJ. 1991. Expression of biologically active human antithrombin III by recombinant baculovirus in Spodoptera frugiperda cells. J Biol Chem 266(6): 3995-4001.
16. Grinna LS, Tschopp JF. 1989. Size distribution and general structural features of N-linked oligosaccharides from the methylotrophic yeast, Pichia pastoris. Yeast 5: 107-115.
17. Hase S, Ibuki T, Ikenaka T. 1984. Reexamination of the pyridylamination used for fluorescence labeling of oligosaccharides and its application to glycoproteins. J Biochem (Tokyo) 95(1): 197-203.
18. Herscovics A, Orlean P. 1993. Glycoprotein biosynthesis in yeast. FASEB J 7: 540-550.
19. Karson EM, Ballou CE. 1978. Biosynthesis of yeast mannan. J Biol Chem 253(18): 6484-6492.
20. Kornfeld R, Kornfeld S. 1985. Assembly of asparagine-linked oligosaccharides. Ann Rev Biochem 54: 631-664.
21. Kukuruzinska MA, Bergh MLE, Jackson BJ. 1987. Protein glycosylation in yeast. Ann Rev Biochem 56: 915-944.
22. Martinet W, Saelens X, Deroo T, et al. 1997. Protection of mice against a lethal influenza challenge by immunization with yeast-derived recombinant influenza neuraminidase. Eur J Biochem 247: 332-338.
23. Miele RG, Castellino FJ, Bretthauer RK. 1997a. Characterization of the acidic oligosaccharides assembled on the Pichia pastoris-expressed recombinant kringle 2 domain of human tissue-type plasminogen activator. Biotechnol Appl Biochem 26: 79-83.
24. Miele RG, Nilsen SL, Brito T, Bretthauer RK, Castellino FJ. 1997b. Glycosylation properties of the Pichia pastoris-expressed recombinant kringle 2 domain of tissue-type plasminogen activator. Biotechnol Appl Biochem 25: 151-157.
25. Mizuochi T, Fujii J, Kurachi K, Kobata A. 1980. Structural studies of the carbohydrate moiety of human antithrombin III. Arch Biochem Biophys 203(1): 458-465.
26. Mochizuki S, Hamato N, Hirose M, et al. 2001. Expression and characterization of recombinant human antithrombin III in Pichia pastoris. Protein Expr Purif 23(1): 55-65.
27. Montesino R, García R, Quintero O, Cremata JA. 1998. Variation in N-linked oligosaccharide structures on heterologous proteins secreted by the methylotrophic yeast Pichia pastoris. Protein Expr Purif 14: 197-207.
28. Murano G, Williams L, Miller-Andersson M, Aronson DL, King C. 1980. Some properties of antithrombin-III and its concentration in human plasma. Thromb Res 18(1-2): 259-262.
29. Nagasu T, Shimma Y, Nakanishi Y, et al. 1992. Isolation of new temperature-sensitive mutants of Saccharomyces cerevisiae deficient in mannose outer chain elongation. Yeast 8(7): 535-547.
30. Nakagawa H, Kawamura Y, Kato K, Shimada I, Arata Y, Takahashi N. 1995. Identification of neutral and sialyl N-linked oligosaccharide structures from human serum glycoproteins using three kinds of high-performance liquid chromatography. Anal Biochem 226: 130-138.
31. Odani T, Shimma Y, Tanaka A, Jigami Y. 1996. Cloning and analysis of the MNN4 gene required for phosphorylation of N-linked oligosaccharides in Saccharomyces cerevisiae. Glycobiology 6(8): 805-810.
32. Peterson CB, Blackburn MN. 1985. Isolation and characterization of an antithrombin III variant with reduced carbohydrate content and enhanced heparin binding. J Biol Chem 260(1): 610-615.
33. Rosenberg RD, Damus PS. 1973. The purification and mechanism of action of human antithrombin-heparin co-factor. J Biol Chem 248(18): 6490-6505.
34. Rosenberg RD, Edelberg JM, Zhang L. 2000. The heparin/antithrombin system: a natural anticoagulant mechanism. In Antithrombin III and Heparin Co-factor II in Hemostasis and Thrombosis, 4th edn, Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN (eds). Lippincott Williams & Wilkins: Philadelphia, PA; 712.
35. Samson D, Stirling Y, Woolf L, Howarth D, Seghatchian MJ, de Chazal R. 1984. Management of planned pregnancy in a patient with congenital antithrombin III deficiency. Br J Haematol 56(2): 243-249.
36. Schipper HG, Jenkins CS, Kahle LH, ten Cate JW. 1978. Antithrombin-III transfusion in disseminated intravascular coagulation. Lancet 1(8069): 854-856.
37. Scorer CA, Buckholz RG, Clare JJ, Romanos MA. 1993. The intracellular production and secretion of HIV-1 envelope protein in the methylotrophic yeast Pichia pastoris. Gene 136: 111-119.
38. Stephens AW, Siddiqui A, Hirs CHW. 1987. Expression of functionally active human antithrombin III. Proc Natl Acad Sci USA 84: 3886-3890.
39. Thieme TR, Ballou CE. 1971. Nature of the phosphodiester linkage of the phosphomannan from the yeast Kloeckera brevis. Biochemistry 10(22): 4121-4129.
40. Tomiya N, Awaya J, Kurono M, Endo S, Arata Y, Takahashi N. 1988. Analyses of N-linked oligosaccharides using a two-dimensional mapping technique. Anal Biochem 171: 73-90.
41. Trimble RB, Atkinson PH, Tschopp JF, Townsend RR, Maley F. 1991. Structure of oligosaccharides on Saccharomyces SUC2 invertase secreted by the methylotrophic yeast Pichia pastoris. J Biol Chem 266(34): 22807 -22817.
42. Wasley LC, Atha DH, Bauer KA, Kaufman RJ. 1987. Expression and characterization of human antithrombin III synthesized in mammalian cells. J Biol Chem 262(30): 14766-14772.
43. Zhu A, Wang Z-K, Beavis R. 1998. Structural studies of α-N-acetylgalactosaminidase: effect of glycosylation on the level of expression, secretion efficiency, and enzyme activity. Arch Biol Biophys 352(1): 1-8.